biologist077.bsky.social
@biologist077.bsky.social
📤 60
📥 945
📝 30
imagine new medicines arriving faster...a new ai model achieved up to 98.8% success optimizing molecules for drug creation. it's designed to speed up the whole process. amazing! Speaking of science — practice English with AI:
https://app.speakfloe.com/#/onboarding/goals
about 4 hours ago
0
0
0
Turns out the blood of people over 100 has some special proteins that look more like those of younger folks. This might point to ways to slow down aging!
about 10 hours ago
0
1
0
used to be, weight loss was just calories in/out. now, early mouse studies show gut bacteria + low protein diets can turn white fat (storage) into beige fat (burn). interesting stuff.
about 16 hours ago
0
4
1
10.7% weight loss! Genentech's phase 2 trial of petrelintide, a new obesity drug, had great results. That's a big jump over placebo. Promising new approach for metabolic health! Been using this to practice my English:
https://app.speakfloe.com/#/onboarding/goals
loading . . .
Genentech Announces Positive Phase II Results for Petrelintide, an Amylin Analog Developed for Peopl
Genentech has reported positive top-line results from its Phase II ZUPREME-1 trial for petrelintide, a new once-weekly injectable drug designed for individuals living with overweight and obesity. The
https://lasvegassun.com/news/2026/mar/05/genentech-announces-positive-phase-ii-results-for-/
about 22 hours ago
0
3
0
Stem cells from baby teeth reduced motor & cognitive issues in rats with cerebral palsy (CP). CP affects 2-3 of 1000 births. Human trials are next! Promising even after symptoms start.
loading . . .
Stem cells from human primary tooth pulp may help treat chronic-phase cerebral palsy
Japanese researchers have conducted rat experiments demonstrating that stem cells derived from human primary tooth pulp, known as SHED, can effectively reduce motor and cognitive impairments associate
https://www.news-medical.net/news/20260304/Stem-cells-from-human-primary-tooth-pulp-may-help-treat-chronic-phase-cerebral-palsy.aspx
1 day ago
1
2
0
Phase 1 data says BV100, an antibiotic for drug-resistant infections, is safe. In Phase 2, it cut deaths in pneumonia patients by 50% compared to current treatments! 💪 Less scary infections for folks in hospitals.
loading . . .
BioVersys Announces Publication of BV100 Phase 1 Clinical Data in Journal of Antimicrobial Agents an
BioVersys has announced the publication of Phase 1 clinical trial data for its novel intravenous antibiotic, BV100, in the Journal of Antimicrobial Agents and Chemotherapy. The data confirm that BV100
https://www.globenewswire.com/news-release/2026/03/04/3249041/0/en/BioVersys-Announces-Publication-of-BV100-Phase-1-Clinical-Data-in-Journal-of-Antimicrobial-Agents-and-Chemotherapy.html
1 day ago
0
0
0
What if AI could help rare disease patients find clinical trials faster? New study: an AI reviewed 1400+ charts in a week & found potential matches missed by normal methods. Speeds things up & could make access more fair. 🤔
1 day ago
1
2
0
scientists found a strong link between the epstein-barr virus (ebv) and multiple sclerosis (ms). it followed 10 million young adults and found that if you get ebv, you're way more likely to get ms later. this could change how we treat ms patients.
loading . . .
Medicine confirms a strong link between the Epstein–Barr virus and multiple sclerosis, according to
A groundbreaking study has revealed a significant connection between the Epstein-Barr virus (EBV) and multiple sclerosis (MS). This discovery provides compelling evidence that EBV may play a crucial r
https://www.thesocialonmain.com.au/medicine-confirms-a-strong-link-between-the-epstein-barr-virus-and-multiple-sclerosis-according-to-recent-research/
2 days ago
0
1
0
alzheimer's is scary. but scientists found that some brain cells have a built-in cleanup system for toxic tau protein (that's the bad stuff that builds up). and they identified CRL5SOCS4, a protein complex, that's key to tagging & destroying it. pretty neat.
loading . . .
Scientists Just Found the Brain's Hidden Defense Against Alzheimer's
Researchers at UCLA Health and UC San Francisco have discovered a natural cleanup system within certain brain cells that actively removes the toxic tau protein, a hallmark of Alzheimer's disease. This
https://www.sciencedaily.com/releases/2026/03/260303145730.htm
2 days ago
0
3
1
Frailty used to be something we just accepted with age. Now a Phase 2 trial shows stem cell therapy (Laromestrocel) improved endurance & reduced frailty in older adults. Reversing aging markers? Quietly revolutionary.
loading . . .
Stem Cell Therapy for Frailty Just Crossed a Major Milestone
A recently published Phase 2b clinical trial demonstrated that a single intravenous dose of Laromestrocel, a mesenchymal stem cell therapy, significantly improved physical endurance and reduced frailt
https://www.lisatamati.com/blog/post/161187/the-science-of-ageing-just-changed/
2 days ago
0
0
0
ovarian cancer: a new drug (alnodesertib) with chemo helped 34 of 100 patients live 6 months without their cancer getting worse. chemo alone? 23 of 100. small, early trial, but worth watching.
loading . . .
Artios Reports Randomized Phase 2a Study of Low Dose Alnodesertib Plus Gemcitabine Achieves Primary
Artios Pharma announced positive results from a Phase 2a clinical trial for alnodesertib, a new DNA Damage Response (DDR) medicine, in combination with gemcitabine for patients with platinum-resistant
https://firstwordpharma.com/story/7123373
3 days ago
0
1
0
Imagine a world where cancer treatment gets to people faster. FDA just approved a lung cancer therapy in record time! Tumors shrank in 76% of patients (a big jump from the usual 30-45%). This is why the lab work matters.
loading . . .
FDA approved new cancer therapy and delivers patient access in just 44 days
The U.S. Food and Drug Administration (FDA) recently approved Boehringer Ingelheim's lung cancer therapy, HERNEXEOS (zongertinib), marking a significant advancement for patients with a specific type o
https://pharmadispatch.com/news/fda-approved-new-cancer-therapy-and-ensures-patient-access-in-just-44-days
3 days ago
0
2
0
Schizophrenia's genetic risk is 73% unique, says a huge study. Bipolar & PTSD are far less so. Why care? Bc if genes overlap, maybe treatments should too. Time to rethink how we target mental illness.
loading . . .
Genetic risk for mental illness is far less disorder-specific than clinicians have assumed, massive
A sweeping new peer-reviewed study published in Genomic Psychiatry has introduced the concept of 'genetic specificity,' challenging long-held assumptions about how unique genetic risks are to individu
https://www.eurekalert.org/news-releases/1036815
3 days ago
0
1
0
Interesting early study: GLP-1 drugs (diabetes/weight loss meds) seem to cut down on ER visits & hospitalizations for people with chronic migraine. A 10-14% drop compared to other preventives.
loading . . .
GLP-1 Drugs Show Surprising Benefits for Chronic Migraine Sufferers
A new preliminary study suggests that GLP-1 receptor agonists, medications primarily used for diabetes and weight loss, may also significantly reduce the burden of chronic migraine. Patients taking th
https://www.news-medical.net/news/20260302/The-surprising-neurological-benefits-of-GLP-1s.aspx
3 days ago
0
0
0
Seaweed molecules 🤝 human skin molecules? Interesting! Early research shows some compounds in green seaweed (ulvan) are similar to what makes up our skin. Could be good for wound healing eventually.
loading . . .
Australian Seaweed Reveals Anti-Aging and Regenerative Skin Secrets
Researchers at the University of Wollongong have discovered that a unique Australian green seaweed contains specific molecules, such as ulvan, which closely mimic the biological functions and foundati
https://www.uow.edu.au/the-stand/2026/antibacterial-anti-inflammatory-anti-ageing-the-healing-power-of-seaweed.php
4 days ago
0
0
0
high schoolers are building surgical robots! their prototype aims for submillimeter accuracy in spine surgery. that's a big deal since current methods have high error rates.
loading . . .
3 Gwinnett County High Schoolers Take on Spine Surgery with Their Robot Prototype
Three 17-year-old high school juniors have developed a prototype for a next-generation surgical robotic system aimed at improving cervical spine surgery. Their computer-aided design models are intende
https://www.medtechdive.com/news/CMR-Surgical-FDA-clearance-Versius-Plus-robot/808140/
4 days ago
0
0
0
Menopause isn't just hot flashes. 3 in 4 women don't know it can *trigger* mental illness, like depression. We need to think of overall health, not just individual symptoms.
loading . . .
Three in four women unaware menopause can trigger new mental illness, poll finds
A new YouGov poll, commissioned by the Royal College of Psychiatrists, reveals that nearly three-quarters of UK women are unaware that menopause can initiate a new mental illness. This significant kno
https://www.theguardian.com/society/2026/mar/01/menopause-mental-illness-royal-college-of-psychiatrists-poll
4 days ago
0
2
0
Remote surgery milestone: French surgeons successfully completed a gastric bypass in India in just 44 minutes using an Indian-made robot. Pretty neat.
loading . . .
France-Based Surgeons Successfully Perform Remote Surgeries on Indian Patients Using Made-in-India R
Surgeons located in France successfully performed two complex remote surgeries, a gastric bypass and a cardiac ASD closure, on patients in India using the indigenously developed SSI Mantra robotic sur
https://www.digitalhealthnews.com/france-based-surgeons-operate-on-indian-patients-using-made-in-india-robot
4 days ago
0
0
0
Advanced kidney cancer got a hopeful boost. A new combo reduced disease progression/death by 30%—that's like 3 more people out of 10 seeing cancer slow down after immunotherapy stopped working. FDA is reviewing.
loading . . .
WELIREG® (belzutifan) Plus LENVIMA® (lenvatinib) Reduces Risk of Disease Progression or Death by 30%
A Phase 3 clinical trial (LITESPARK-011) has shown that a combination of WELIREG and LENVIMA significantly reduced the risk of disease progression or death by 30% in patients with advanced renal cell
https://www.eisai.com/news/2026/news202611.html
5 days ago
0
0
0
AI's impact: 2 drug molecules are now in clinical trials! This isn't replacing scientists, but accelerating our work to treat diseases faster. That's a win for patients!
loading . . .
MSD's AI Models Advance Two Drug Molecules into Clinical Trials, Emphasizing Human-AI Collaboration
MSD's Chief AI Officer, Anton Groom, revealed that the company is utilizing AI models, such as TEDDY and KERMT, to enhance drug discovery by identifying new targets and refining lead identification. T
https://m.economictimes.com/ai/ai-insights/all-our-ai-models-have-scientists-in-loop-says-msd-chief-ai-officer/articleshow/128916256.cms
5 days ago
0
1
0
First trimester bleeding is common (25%!). Bleeding + a dating ultrasound lagging by >5 days, *not* the bleeding alone, is what the study linked to increased risk of pregnancy loss. Something to know.
loading . . .
Early Bleeding Alone Not Tied to Pregnancy Loss Risk
A new study indicates that while approximately one in four women experience bleeding in their first trimester, this bleeding alone does not increase the risk of pregnancy loss. However, if this bleedi
https://www.medscape.com/viewarticle/early-bleeding-alone-not-tied-pregnancy-loss-risk-2026a100069u
5 days ago
0
0
0
fda just approved a combo therapy for metastatic colorectal cancer (mCRC) with a specific BRAF mutation. the BREAKWATER trial saw a 51% reduction in risk of death! 🙌
loading . . .
U.S. FDA Grants Full Approval to Pfizer's BRAFTOVI Combination Regimen in First-Line Metastatic Colo
The U.S. Food and Drug Administration (FDA) has granted full approval to Pfizer's BRAFTOVI (encorafenib) in combination with cetuximab and fluorouracil-based chemotherapy for adults with metastatic co
https://www.pfizer.com/news/press-release/press-release-detail/us-fda-grants-full-approval-pfizers-braftovi-combination
6 days ago
0
0
0
billions spent targeting amyloid beta in alzheimer's, but new research suggests we've been looking at the wrong culprit. a "neglected cousin" peptide called P3 might form toxic clumps even faster 😬
6 days ago
0
0
0
New flu variants are spreading, so the WHO updated its vaccine recommendations for the '26-'27 flu season! It's important work to match vaccines to the real threats and prep for future pandemics.
6 days ago
0
0
0
Measles cases in the US have topped 1100 this year. 92% of those folks were unvaxxed or their vax status was unknown. That puts us at risk of losing our "measles eliminated" status. Important for herd immunity, folks!
loading . . .
US Measles Cases Skyrocket Past 1,100, Threatening Disease-Free Status
The United States has reported 1,136 measles cases so far this year, a sharp increase that puts the nation at risk of losing its measles-elimination status, a designation held since 2001. This resurge
https://www.cidrap.umn.edu/measles/us-measles-cases-soar-past-1100
6 days ago
0
0
0
Imagine needing a totally unique gene therapy... FDA might speed those up for ultra-rare diseases? So cool! It's about custom CRISPR treatments when only a few people worldwide have a condition.
7 days ago
0
1
0
New cell therapy (RB-1355) showed promise in early trials for aggressive lymphomas. In 13 patients, 2 who didn't respond to CAR-T (a different cell therapy) had complete remission. Small study, but encouraging!
7 days ago
0
1
1
Good news for wAIHA patients! Johnson & Johnson is seeking FDA approval for nipocalimab, a drug that, in trials, helped more people achieve stable hemoglobin (a key component of red blood cells). A possible new option to treat this rare anemia.
loading . . .
Johnson & Johnson seeks FDA approval of IMAAVY® (nipocalimab-aahu) as the first-ever FDA-approved tr
Johnson & Johnson has submitted an application to the U.S. Food and Drug Administration (FDA) for the approval of its drug, IMAAVY® (nipocalimab-aahu), to treat warm autoimmune hemolytic anemia (wAIHA
https://www.jnj.com/media-center/press-releases/johnson-johnson-seeks-fda-approval-of-imaavy-nipocalimab-aahu-as-the-first-ever-fda-approved-treatment-for-warm-autoimmune-hemolytic-anemia-waiha
7 days ago
0
0
0
90% of prostate tumors had microplastics inside. 🤯 Turns out the cancerous tissue had WAY more plastic than healthy tissue. Still early, but could change how we think about cancer risk.
loading . . .
Microplastics found in 90% of prostate cancer tumors, study reveals
A new study has revealed the presence of microplastics in nearly all prostate cancer tumors examined, with cancerous tissue containing significantly higher concentrations than healthy prostate tissue.
https://www.sciencedaily.com/releases/2026/02/260225001250.htm
7 days ago
0
1
1
New hope for HER2-mutated non-small cell lung cancer (NSCLC) patients. Zongertinib is the first targeted treatment, showing a 76% response rate in early trials. A step towards more personalized cancer care.
loading . . .
FDA Grants Accelerated Approval to Zongertinib (Hernexeos) for HER2-Mutated NSCLC
The FDA has granted accelerated approval to zongertinib (Hernexeos) for adults with HER2-mutated, unresectable or metastatic non-small cell lung cancer (NSCLC) who have not received prior systemic the
https://www.boehringer-ingelheim.com/us/human-health/cancer/lung-cancer/fda-approves-targeted-therapy-her2-mutant-advanced-nsclc
7 days ago
0
7
1
you reached the end!!
feeds!
log in